Activation of G6PD, a ‘metabolic checkpoint’ that controls glucose metabolic flux partitioning between aerobic glycolysis and the pentose phosphate pathway, increases Gzmb expression in tumor-specific CTLs (81). Here, G6PD is linked to neoplasm.